Simplified recombinational approach for influenza A virus reverse genetics.

Area of Science:

• Virology
• Molecular Biology
• Genetic Engineering

Background:

• Traditional influenza A virus (FLUAV) reverse genetics relies on cloning eight genome segments into expression plasmids via restriction enzyme digestion and ligation.
• This process is time-consuming and complex, potentially delaying crucial research and vaccine production.

Purpose of the Study:

• To develop a simplified and more efficient method for constructing genomic expression plasmids for FLUAV reverse genetics.
• To reduce the time and complexity associated with generating viral genome constructs.

Main Methods:

• Construction of two novel plasmid vectors, pHH21A and pHH21G, featuring a recombination cassette with consensus 5' and 3' ends.
• Utilizing RecA-assisted homologous recombination in Escherichia coli for direct cloning of influenza cDNA into the plasmid vectors.
• Employing a StuI cleavage site within the recombination cassette, with variations (A or G) to accommodate different genome segments.

Main Results:

• Successfully cloned viral cDNA genomes from various avian and human FLUAV strains into genomic expression plasmids in a single recombination step.
• Demonstrated that the novel recombinational approach avoids restriction digestion and ligation, simplifying the cloning process.
• Maintained the required orientation of genome segments during the recombination process.

Conclusions:

• The developed recombinational cloning strategy offers a significant improvement over traditional methods for FLUAV reverse genetics.
• This simplified approach accelerates the generation of viral genome constructs, facilitating faster vaccine production and biological analysis.
• The method is versatile, applicable to diverse FLUAV strains, and reduces procedural complexity.